Table 1.
Reference | Study design | Inclusion criteria | Indication | n | Male sex | Age (years) |
Primary stoma | NART | Adjunct treatment (%) |
---|---|---|---|---|---|---|---|---|---|
Mees et al.29 | Prospective matched cohort | Symptomatic leak after AR or IPAA | Rectal cancer and UC | 5 | 4 of 5 | 47 | n.a. | 0 of 5 | None |
Glitsch et al.30 | Prospective case series | Symptomatic leak after AR or colectomy with extraperitoneal anastomosis | Rectal cancer | 17 | 14 of 17 | 61 | 8 of 17 | 9 of 17 | 15 Fibrin glue |
van Koperen et al.18 | Prospective case series | Symptomatic leak after AR or IPAA | Rectal cancer and UC | 16 | 9 of 16 | 64 | 8 of 16 | 11 of 16 | None |
von Bernstorff et al.19 | Prospective case series | Symptomatic leak after AR | Rectal cancer | 26 | 21 of 26 | 58 | 14 of 26 | 14 of 26 | None |
Chopra et al.31 | Retrospective cohort | Symptomatic leak after AR | Rectal cancer | 5 | n.a. | n.a. | n.a. | 5 of 5 | Fibrin glue: 2 |
Riss et al.32 | Retrospective case series | Symptomatic leak after AR or Hartmann insufficiency | Rectal cancer | 9 | 5 of 9 | 64 | 4 of 9 | 4 of 9 | None |
Verlaan et al.25 | Prospective case series | Symptomatic leak after AR or IPAA | Rectal cancer and UC or FAP | 6 | 5 of 6 | 50 | 0 | 1 of 6 | ESC: 4 Clip: 1 |
Srinivasamurthy et al.33 | Retrospective case series | Extraperitoneal anastomosis and symptomatic leak after AR or IPAA | Rectal cancer and UC | 8 | 7 of 8 | 67 | n.a. | 7 of 8 | None |
Nerup et al.23 | Retrospective case series | Symptomatic leak after AR | Rectal cancer | 13 | 11 of 13 | 64 | 13 of 13 | 6 of 13 | None |
Keskin et al.34 | Retrospective case series | Symptomatic leak after AR, IPAA or IRA | Rectal cancer, FAP and diverticular disease | 15 | 7 of 15 | 55 | 14 of 15 | 6 of 15 | None |
Arezzo et al.35 | Retrospective case series | Symptomatic leak after AR, TEM or STARR | Rectal cancer, rectal adenoma, RV fistula | 14 | 7 of 14 | 68 | 8 of 14 | 7 of 14 | Glue and clip |
Strangio et al.36 | Prospective case series | Symptomatic leak after AR, IPAA or left colectomy | Rectal cancer, endometriotic nodule, UC, colonic cancer, diverticulitis | 25 | 18 of 25 | 67 | 13 of 25 | 8 of 25 | None |
Kuehn et al.37 | Retrospective case series | Symptomatic leak after AR, Hartmann insufficiency, IPAA, TEM or STARR | Rectal cancer, diverticulitis, UC, rectal perforation, UC, fistula | 41 | 31 of 41 | 70 | 19 of 19 | 12 of 41 | None |
Mussetto et al.38 | Retrospective case series | Symptomatic leak after AR | Rectal cancer | 11 | 6 of 11 | 71 | n.a. | 5 of 11 | None |
Milito et al.39 | Prospective case series | AL of low rectal anastomosis | Rectal cancer | 14 | 10 of 14 | 65 | 14 of 14 | 14 of 14 | None |
Mencio et al.40 | Retrospective case series | Patients with different GI leaks | n.a. | 10 | 5 of 10 | 55 | 7 of 10 | n.a. | None |
Jimenez-Rodriguez et al.41 | Prospective case series | Symptomatic leak after AR or Hartmann insufficiency | Rectal cancer | 22 | 18 of 22 | 65 | 13 of 22 | 17 of 22 | Fibrin glue: 10 |
Borstlap et al.21 | Prospective case series | Symptomatic leak after AR | Rectal cancer | 30 | 19 of 30 | 66 | 23 of 30 | 22 of 30 | ESC: 30 |
Rottoli et al.42 | Prospective case series | Symptomatic leak after IPAA | UC and FAP | 8 | n.a. | 37 | 8 of 8 | 0 of 8 | None |
Katz et al.43 | Retrospective case series | Symptomatic leak after AR, IPAA | Rectal cancer, Hirschprung, FAP, ovarian cancer with rectal involvement | 6 | 5 of 6 | 54 | 3 of 6 | n.a. | None |
Wasmann et al.22 | Retrospective cohort | Symptomatic leak after IPAA | UC | 18 | 12 of 18 | 41 | 1 of 18 | 0 of 18 | ESC: 18 |
Boschetti et al.44 | Retrospective case series | Symptomatic leakage | Colonic cancer, rectal cancer, sigmoiditis | 29 | 22 of 29 | 68 | 12 of 29 (41.4) | 19 of 29 (65.5) | None |
Huisman et al.45 | Retrospective cohort | Symptomatic leakage after rectal surgery | Rectal cancer, IBD | 20 | 14 of 20 | 64 | 14 of 20 | 14 of 20 | ESC: 3 |
Kantowski46 | Retrospective case series | AL after colorectal resection | Rectal cancer, diverticular disease, IBD, ischaemia | 89 | 68 of 89 | 58 | 87 of 89 | 27 of 89 | Transanal rinsing therapy after EVT: 58 |
Abdalla et al.47 | Prospective case series | Leakage after elective proctectomy | Rectal cancer, IBD | 47 | 36 of 47 | 65 | 40 of 47 | 27 of 47 | None |
Weréen et al.48 | Retrospective cohort study | Symptomatic leakage after AR | Rectal cancer | 14 | 9 of 14 | 64 | 12 of 14 | 13 of 14 | None |
Kühn et al.49 | Prospective case series | Colorectal defects | Rectal cancer, IBD, diverticular disease, other malignancies, perforation | 281 | 186 of 281 | 65 | 224 of 281 | 95 of 281 | None |
Jagielski et al.50 | Prospective cohort study | AL after rectal cancer surgery | Rectal cancer | 18 | 18 of 18 | 61 | 8 of 18 | 16 of 18 | None |
Keshvari et al.51 | Prospective case series | AL after LAR | Rectal cancer | 10 | 6 of 10 | 56 | 10 of 10 | 10 of 10 | None |
Values in parentheses are percentages. NART, neoadjuvant radiotherapy; (L)AR, (low) anterior resection; IPAA, ileal pouch–anal anastomosis; UC, ulcerative colitis; n.a., not available; FAP, familial adenomatous polyposis; ESC, early surgical closure; IRA, ileorectal anastomosis; TEM, transanal endoscopic microsurgery; STARR, stapled transanal rectal resection; RV, rectovaginal; GI, gastrointestinal; IBD, inflammatory bowel disease; AL, anastomotic leakage; EVT, endoscopic vacuum therapy.